fbpx

New program from Hoya and Clarion

 

Hoya Vision Care Canada sealed a strategic partnership with Clarion Medical Technologies, one of the country’s largest private medical companies, to offer a loyalty and benefit program to eyecare professionals.

 

With the purchase of Clarion equipment or Hoya lenses, eyecare professionals become eligible for rebates toward the purchase of the equipment. Program details are available from Clarion and Hoya representatives. This partnership has already enabled many ECPs to enjoy increased purchasing power. The OCT programs based on the Optovue iVue and iWellnessEXAM systems have been very well received in the marketplace.

 

“We are pleased to be working with Clarion Medical Technologies on this program,” said David Pietrobon, president, Hoya Vision Care Canada. “They are a very strong partner in the Canadian vision marketplace. We both share a commitment and dedication to patient well-being and practice growth as well as a commitment to cutting-edge technology.”

 

The executive vice president of Clarion Medical Technologies, Joseph Arango, described Hoya as being the “perfect choice for this alliance,” given their business philosophy and understanding of the optometrist’s needs.

 

 

Featured Posts

SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read More
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read More
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read More
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read More
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more